Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1(RS)-baclofen, naltrexone hydrochloride and D-sorbitol3件: Baclofen,
Naltrexone,
Sorbitol		3件: D00096 ,
D00241 ,
D05113 (Name: Naltrexone)		5件: GABBR1,
GABBR2,
OPRD1,
OPRK1,
OPRM1 💬		9件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 10
24.5 mg Naltrexone1件: Naltrexone1件: D05113 (Name: Naltrexone)3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
3Low dose naltrexone1件: Naltrexone1件: D05113 (Name: Naltrexone)3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 96, 97
4Low-dose naltrexone1件: Naltrexone1件: D05113 (Name: Naltrexone)3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
5NAL----2件: 6, 299
6Nalbuphine1件: Nalbuphine1件: D08246 (Name: Nalbuphine)3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85
7Nalbuphine ER1件: Nalbuphine1件: D08246 (Name: Nalbuphine)3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85
8Nalbuphine Extended-Realease (ER) Tablets1件: Nalbuphine1件: D08246 (Name: Nalbuphine)3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85
9Nalbuphine Extended-Release (ER) Tablets1件: Nalbuphine1件: D08246 (Name: Nalbuphine)3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85
10NALBUPHINE HYDROCHLORIDE1件: Nalbuphine1件: D08246 (Name: Nalbuphine)3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85
11Nalmefene1件: Nalmefene1件: D05111 (Name: Nalmefene)3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
12Naloxone1件: Naloxone1件: D08249 (Name: Naloxone)3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 6, 226
13NALOXONE HYDROCHLORIDE1件: Naloxone1件: D08249 (Name: Naloxone)3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
14NALOXONE HYDROCHLORIDE DIHYDRATE1件: Naloxone1件: D08249 (Name: Naloxone)3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
15Naltrexone1件: Naltrexone1件: D05113 (Name: Naltrexone)3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬12件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226
16NALTREXONE CLORIDRATO1件: Naltrexone1件: D05113 (Name: Naltrexone)3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 10
17NALTREXONE HYDROCHLORIDE1件: Naltrexone1件: D05113 (Name: Naltrexone)3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬8件: 10, 40, 41, 42, 43, 44, 45, 96
18Naltrexone-HCl1件: Naltrexone1件: D05113 (Name: Naltrexone)3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 96
19Oxycodone naloxone prolonged release tablets2件: Naloxone,
Oxycodone (Synonym: Nalocet)		2件: D05312 ,
D08249 (Name: Naloxone)		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
20Oxycodone/naloxone prolonged release t3件: Manganese citrate,
Naloxone,
Oxycodone (Synonym: Nalocet)		2件: D05312 ,
D08249 (Name: Naloxone)		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
21Oxycodone/Naloxone Prolonged Release tablets2件: Naloxone,
Oxycodone (Synonym: Nalocet)		2件: D05312 ,
D08249 (Name: Naloxone)		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
22Oxycodone/naloxone prolonged release tablets 10 mg /5 mg3件: Manganese citrate,
Naloxone,
Oxycodone (Synonym: Nalocet)		2件: D05312 ,
D08249 (Name: Naloxone)		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
23Oxycodone/naloxone prolonged release tablets 10/5 mg3件: Manganese citrate,
Naloxone,
Oxycodone (Synonym: Nalocet)		2件: D05312 ,
D08249 (Name: Naloxone)		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
24Oxycodone/naloxone prolonged release tablets 20 mg /10 mg3件: Manganese citrate,
Naloxone,
Oxycodone (Synonym: Nalocet)		2件: D05312 ,
D08249 (Name: Naloxone)		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
25Oxycodone/naloxone prolonged release tablets 20/10 mg3件: Manganese citrate,
Naloxone,
Oxycodone (Synonym: Nalocet)		2件: D05312 ,
D08249 (Name: Naloxone)		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
26Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg3件: Manganese citrate,
Naloxone,
Oxycodone (Synonym: Nalocet)		2件: D05312 ,
D08249 (Name: Naloxone)		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
27Oxycodone/naloxone prolonged release tablets 5/2.5 mg3件: Manganese citrate,
Naloxone,
Oxycodone (Synonym: Nalocet)		2件: D05312 ,
D08249 (Name: Naloxone)		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226